Trial Profile
An open label, randomised, four period, partial crossover study to evaluate the absolute bioavailability and effect of food on the pharmacokientics of oral/I.V. Odanacatib in healthy postmenopausal women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Aug 2016
Price :
$35
*
At a glance
- Drugs Odanacatib (Primary) ; Odanacatib (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacokinetics
- 23 Aug 2016 New trial record